Skip to main content
Retour
Watch Compare

Accustem Sciences Inc.

Qualité des données : 83%
ACUT
OTC Manufacturing Chemicals
0,27 €
▼ 0,02 € (-5,36%)
Cap. Boursière: 4,26 M
Prix
0,27 €
Cap. Boursière
4,26 M
Fourchette du Jour
0,27 € — 0,27 €
Fourchette 52 Semaines
0,27 € — 2,33 €
Volume
300
Ouverture 0,27 €
Moyenne 50J / 200J
0,48 €
44,28% below
Moyenne 50J / 200J
1,01 €
73,68% below

Quick Summary

Points Clés

Negative free cash flow of -872 332,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,35
Interest CoverageN/A

Valorisation

PE (TTM)
-2,64
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,6 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -1,61 M
ROE N/A ROA -101,28%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -872 332,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,35
Interest Coverage N/A Asset Turnover N/A
Working Capital -2,91 M Tangible Book Value -2,91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,64 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -20,48%
Market Cap 4,26 M Enterprise Value 4,26 M
Per Share
EPS (Diluted TTM) -0,11 Revenue / Share N/A
FCF / Share -0,05 OCF / Share -0,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 54,05%
SBC-Adj. FCF -956 200 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue — — —
Net Income -1,51 M -2,05 M -3,75 M
EPS (Diluted) -0,13 -0,18 —
Gross Profit — — —
Operating Income -1,51 M -2,05 M -3,75 M
EBITDA — — —
R&D Expenses 138 324,0 139 663,0 266 933,0
SG&A Expenses — — —
D&A — — —
Interest Expense — — —
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 50 851,0 133 897,0 939 689,0
Total Liabilities 3,36 M 2,25 M 1,08 M
Shareholders' Equity -3,31 M -2,11 M -139 550,0
Total Debt — — —
Cash & Equivalents — — —
Current Assets 50 433,0 129 849,0 932 011,0
Current Liabilities 3,36 M 2,25 M 1,08 M